NASDAQ:REGN   Regeneron Pharmaceuticals, Inc.
+ Phase 3 data due June 2020 -> Signal for the Bull.
Comment:
+ Reset near $533.64 and long target will be $605.88 (ATH)
+ Just my idea, use as reference. Not an advice
Comment:
Hit $533.64, will hold support. Looking for further movement. Congrats whoever follow the plan
Comment:
Hell yeah my baby
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.